The project aims to prove a complete cure for diabetes by targeting and eliminating abnormal hematopoietic stem cells, known as Diabetes Stem Cells (DSCs), using a combination of HDAC inhibitors, 5-ALA, and Biozipcode™ drug delivery technology.